Annual Net Income
$21.59 M
+$21.59 M+1079450.00%
December 31, 2023
Summary
- As of February 7, 2025, PBYI annual net profit is $21.59 million, with the most recent change of +$21.59 million (+1079450.00%) on December 31, 2023.
- During the last 3 years, PBYI annual net income has risen by +$81.59 million (+135.99%).
- PBYI annual net income is now at all-time high.
Performance
PBYI Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
$20.32 M
+$24.85 M+548.60%
September 30, 2024
Summary
- As of February 7, 2025, PBYI quarterly net profit is $20.32 million, with the most recent change of +$24.85 million (+548.60%) on September 30, 2024.
- Over the past year, PBYI quarterly net income has increased by +$14.52 million (+250.53%).
- PBYI quarterly net income is now at all-time high.
Performance
PBYI Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
$23.24 M
+$14.52 M+166.53%
September 30, 2024
Summary
- As of February 7, 2025, PBYI TTM net profit is $23.24 million, with the most recent change of +$14.52 million (+166.53%) on September 30, 2024.
- Over the past year, PBYI TTM net income has increased by +$19.52 million (+525.26%).
- PBYI TTM net income is now at all-time high.
Performance
PBYI TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
PBYI Net Income Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +10000.0% | +250.5% | +525.3% |
3 y3 years | +136.0% | +116.8% | +167.4% |
5 y5 years | +119.0% | +116.8% | +167.4% |
PBYI Net Income Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +174.1% | at high | +462.4% | at high | +147.5% |
5 y | 5-year | at high | +128.6% | at high | +145.5% | at high | +128.2% |
alltime | all time | at high | +107.4% | at high | +126.1% | at high | +107.7% |
Puma Biotechnology Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $20.32 M(-548.6%) | $23.24 M(+166.5%) |
Jun 2024 | - | -$4.53 M(-5.9%) | $8.72 M(-43.3%) |
Mar 2024 | - | -$4.82 M(-139.2%) | $15.38 M(-28.8%) |
Dec 2023 | $21.59 M(>+9900.0%) | $12.27 M(+111.7%) | $21.59 M(+480.9%) |
Sep 2023 | - | $5.80 M(+172.6%) | $3.72 M(-252.4%) |
Jun 2023 | - | $2.13 M(+51.7%) | -$2.44 M(-150.7%) |
Mar 2023 | - | $1.40 M(-125.0%) | $4.81 M(>+9900.0%) |
Dec 2022 | $2000.00(-100.0%) | -$5.61 M(+1457.2%) | $2000.00(-100.0%) |
Sep 2022 | - | -$360.00 K(-103.8%) | $9.83 M(-128.5%) |
Jun 2022 | - | $9.37 M(-375.4%) | -$34.48 M(-29.6%) |
Mar 2022 | - | -$3.40 M(-180.6%) | -$48.96 M(+68.7%) |
Dec 2021 | -$29.13 M(-51.5%) | $4.22 M(-109.5%) | -$29.03 M(-39.8%) |
Sep 2021 | - | -$44.67 M(+774.9%) | -$48.24 M(+37.7%) |
Jun 2021 | - | -$5.11 M(-130.9%) | -$35.03 M(+32.0%) |
Mar 2021 | - | $16.53 M(-210.2%) | -$26.53 M(-55.8%) |
Dec 2020 | -$59.99 M(-20.6%) | -$14.99 M(-52.3%) | -$59.99 M(+6.8%) |
Sep 2020 | - | -$31.46 M(-1026.7%) | -$56.20 M(+35.0%) |
Jun 2020 | - | $3.40 M(-120.0%) | -$41.62 M(-49.5%) |
Mar 2020 | - | -$16.93 M(+51.2%) | -$82.44 M(+9.1%) |
Dec 2019 | -$75.59 M(-33.4%) | -$11.20 M(-33.7%) | -$75.59 M(-20.5%) |
Sep 2019 | - | -$16.89 M(-54.9%) | -$95.09 M(+2.9%) |
Jun 2019 | - | -$37.42 M(+271.0%) | -$92.41 M(-7.0%) |
Mar 2019 | - | -$10.09 M(-67.1%) | -$99.32 M(-12.6%) |
Dec 2018 | -$113.58 M(-61.1%) | -$30.70 M(+116.1%) | -$113.58 M(-22.7%) |
Sep 2018 | - | -$14.20 M(-68.0%) | -$146.96 M(-30.0%) |
Jun 2018 | - | -$44.34 M(+82.1%) | -$209.94 M(-13.8%) |
Mar 2018 | - | -$24.34 M(-62.0%) | -$243.44 M(-16.6%) |
Dec 2017 | -$291.95 M(+5.8%) | -$64.08 M(-17.0%) | -$291.95 M(-2.9%) |
Sep 2017 | - | -$77.18 M(-0.8%) | -$300.54 M(+3.9%) |
Jun 2017 | - | -$77.83 M(+6.8%) | -$289.14 M(+4.0%) |
Mar 2017 | - | -$72.86 M(+0.3%) | -$277.90 M(+0.7%) |
Dec 2016 | -$276.01 M | -$72.66 M(+10.5%) | -$276.01 M(+4.1%) |
Sep 2016 | - | -$65.78 M(-1.2%) | -$265.07 M(+2.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2016 | - | -$66.60 M(-6.2%) | -$259.70 M(+0.7%) |
Mar 2016 | - | -$70.97 M(+15.0%) | -$257.80 M(+7.7%) |
Dec 2015 | -$239.28 M(+68.6%) | -$61.72 M(+2.2%) | -$239.28 M(+6.3%) |
Sep 2015 | - | -$60.42 M(-6.6%) | -$225.05 M(+12.3%) |
Jun 2015 | - | -$64.69 M(+23.3%) | -$200.47 M(+14.8%) |
Mar 2015 | - | -$52.45 M(+10.5%) | -$174.63 M(+23.0%) |
Dec 2014 | -$141.97 M(+159.7%) | -$47.48 M(+32.5%) | -$141.97 M(+28.6%) |
Sep 2014 | - | -$35.84 M(-7.7%) | -$110.43 M(+24.3%) |
Jun 2014 | - | -$38.84 M(+96.2%) | -$88.87 M(+41.8%) |
Mar 2014 | - | -$19.79 M(+24.1%) | -$62.67 M(+14.7%) |
Dec 2013 | -$54.66 M(-26.5%) | -$15.95 M(+11.6%) | -$54.66 M(-9.8%) |
Sep 2013 | - | -$14.28 M(+12.9%) | -$60.63 M(-16.0%) |
Jun 2013 | - | -$12.65 M(+7.4%) | -$72.20 M(-2.8%) |
Mar 2013 | - | -$11.78 M(-46.2%) | -$74.31 M(-0.1%) |
Dec 2012 | -$74.35 M(+626.6%) | -$21.91 M(-15.3%) | -$74.35 M(+19.4%) |
Sep 2012 | - | -$25.86 M(+75.3%) | -$62.29 M(+69.4%) |
Jun 2012 | - | -$14.75 M(+24.8%) | -$36.77 M(+66.7%) |
Mar 2012 | - | -$11.83 M(+20.1%) | -$22.06 M(+115.5%) |
Dec 2011 | -$10.23 M(>+9900.0%) | -$9.85 M(+2734.6%) | -$10.23 M(+2576.7%) |
Sep 2011 | - | -$347.40 K(+912.8%) | -$382.30 K(+903.4%) |
Jun 2011 | - | -$34.30 K(+779.5%) | -$38.10 K(+514.5%) |
Mar 2011 | - | -$3900.00(-218.2%) | -$6200.00(-11.4%) |
Dec 2010 | -$7000.00(-58.3%) | $3300.00(-203.1%) | -$7000.00(-48.5%) |
Sep 2010 | - | -$3200.00(+33.3%) | -$13.60 K(-0.7%) |
Jun 2010 | - | -$2400.00(-48.9%) | -$13.70 K(-11.6%) |
Mar 2010 | - | -$4700.00(+42.4%) | -$15.50 K(-7.7%) |
Dec 2009 | -$16.80 K(+19.1%) | -$3300.00(0.0%) | -$16.80 K(+7.0%) |
Sep 2009 | - | -$3300.00(-21.4%) | -$15.70 K(-4.3%) |
Jun 2009 | - | -$4200.00(-30.0%) | -$16.40 K(+5.1%) |
Mar 2009 | - | -$6000.00(+172.7%) | -$15.60 K(+10.6%) |
Dec 2008 | -$14.10 K | -$2200.00(-45.0%) | -$14.10 K(+18.5%) |
Sep 2008 | - | -$4000.00(+17.6%) | -$11.90 K(+50.6%) |
Jun 2008 | - | -$3400.00(-24.4%) | -$7900.00(+75.6%) |
Mar 2008 | - | -$4500.00 | -$4500.00 |
FAQ
- What is Puma Biotechnology annual net profit?
- What is the all time high annual net income for Puma Biotechnology?
- What is Puma Biotechnology annual net income year-on-year change?
- What is Puma Biotechnology quarterly net profit?
- What is the all time high quarterly net income for Puma Biotechnology?
- What is Puma Biotechnology quarterly net income year-on-year change?
- What is Puma Biotechnology TTM net profit?
- What is the all time high TTM net income for Puma Biotechnology?
- What is Puma Biotechnology TTM net income year-on-year change?
What is Puma Biotechnology annual net profit?
The current annual net income of PBYI is $21.59 M
What is the all time high annual net income for Puma Biotechnology?
Puma Biotechnology all-time high annual net profit is $21.59 M
What is Puma Biotechnology annual net income year-on-year change?
Over the past year, PBYI annual net profit has changed by +$21.59 M (+1079450.00%)
What is Puma Biotechnology quarterly net profit?
The current quarterly net income of PBYI is $20.32 M
What is the all time high quarterly net income for Puma Biotechnology?
Puma Biotechnology all-time high quarterly net profit is $20.32 M
What is Puma Biotechnology quarterly net income year-on-year change?
Over the past year, PBYI quarterly net profit has changed by +$14.52 M (+250.53%)
What is Puma Biotechnology TTM net profit?
The current TTM net income of PBYI is $23.24 M
What is the all time high TTM net income for Puma Biotechnology?
Puma Biotechnology all-time high TTM net profit is $23.24 M
What is Puma Biotechnology TTM net income year-on-year change?
Over the past year, PBYI TTM net profit has changed by +$19.52 M (+525.26%)